321
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Prognostic factors and long-term survival in renal cell cancer patients

, , , , , & show all
Pages 454-460 | Received 18 Feb 2009, Accepted 21 Aug 2009, Published online: 08 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tuija Väänänen, Jukka Kallio, Katriina Vuolteenaho, Alexandra Ojala, Tiina Luukkaala, Mari Hämäläinen, Teuvo Tammela, Pirkko-Liisa Kellokumpu-Lehtinen & Eeva Moilanen. (2017) High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker. Scandinavian Journal of Urology 51:5, pages 367-372.
Read now
Patrick J. Eulitt, Margaret A. Park, Hamed Hossein, Nichola Cruikshanks, Chen Yang, Igor P. Dmitriev, Adly Yacoub, David T. Curiel, Paul B. Fisher & Paul Dent. (2010) Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery . Cancer Biology & Therapy 10:12, pages 1290-1305.
Read now

Articles from other publishers (13)

Vera Miranda-Gonçalves, Catarina Guimarães-Teixeira, Rui Henrique & Carmen Jerónimo. 2021. Epigenetics and Metabolomics. Epigenetics and Metabolomics 107 145 .
Yu Guang Tan, Mohamad Farhan Bin Khalid, Andre Villanueva, Hong Hong Huang, Kenneth Chen & Allen Soon Phang Sim. (2020) Are small renal masses all the same?. International Journal of Urology 27:5, pages 439-447.
Crossref
Masayoshi Zaitsu, Satoshi Toyokawa, Takumi Takeuchi, Yasuki Kobayashi & Ichiro Kawachi. (2019) Sex‐specific analysis of renal cell carcinoma histology and survival in Japan: A population‐based study 2004 to 2016. Health Science Reports 3:1.
Crossref
Ana Lameirinhas, Vera Miranda-Gonçalves, Rui Henrique & Carmen Jerónimo. (2019) The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma. Genes 10:4, pages 264.
Crossref
Gail S. Smith, Carolyn K. Donaldson & Richard M. Gore. 2019. Smith's Textbook of Endourology. Smith's Textbook of Endourology 1391 1424 .
Jukka Kallio, Mari Hämäläinen, Tiina Luukkaala, Eeva Moilanen, Teuvo L. Tammela & Pirkko-Liisa Kellokumpu-Lehtinen. (2017) Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer. Urologic Oncology: Seminars and Original Investigations 35:9, pages 544.e25-544.e31.
Crossref
. 2016. Diagnostic Pathology: Genitourinary. Diagnostic Pathology: Genitourinary 6 11 .
REN-FU CHEN, YUE-YAN LI, LIAN-TAO LI, QIAN CHENG, GUAN JIANG & JUN-NIAN ZHENG. (2015) Novel oncolytic adenovirus sensitizes renal cell carcinoma cells to radiotherapy via mitochondrial apoptotic cell death. Molecular Medicine Reports 11:3, pages 2141-2146.
Crossref
Chao-Nan Qian. (2013) Hijacking the vasculature in ccRCC—co-option, remodelling and angiogenesis. Nature Reviews Urology 10:5, pages 300-304.
Crossref
Gail S. Smith, Carolyn K. Donaldson & Richard M. Gore. 2012. Smith's Textbook of Endourology. Smith's Textbook of Endourology 1297 1326 .
Eirikur Guðmundsson, Henrik Hellborg, Sven Lundstam, Stina Erikson & Börje Ljungberg. (2011) Metastatic Potential in Renal Cell Carcinomas ≤7cm: Swedish Kidney Cancer Quality Register Data. European Urology 60:5, pages 975-982.
Crossref
. (2010) Current World Literature. Current Opinion in Urology 20:5, pages 443-451.
Crossref
Sarel Halachmi, Boaz xMoskovitz & Ofer Nativ. (2010) Tumor Recurrence Following Nephron-Sparing Surgery for Renal Cancer: Rate, Patterns, and Predictors. UroToday International Journal 03:06.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.